Informa is offering a free webinar, “Psychedelics in CNS Therapeutics: Why Interest is Surging and What to Expect Next” on July 20 at 11:00 am EDT. Click the link for info and to register.
Recent entries tagged "nolink"
He received the 2021 Bowl of Hygeia Award for Arizona. It recognizes pharmacists who have “outstanding records of civic leadership and encourage pharmacists to take active roles in their communities.” No argument there.
… and discuss how “The FDA’s weak drug manufacturing oversight is a potentially deadly problem”.
If Medicare has to pay for Biogen’s Aduhelm questionable Alzheimer’s drug it could cost taxpayers more than the entire budget for NASA.
The new position statement from the American Academy of Sleep Medicine declares, “Sleep is essential to health”.
For the first time in quite a while, FDA has updated its pending 503B list — the “Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act”. Interested in what’s on the list and in what category? Click here.
California AB 1533, which would require the state’s board of pharmacy to have at least one representative from a compounding pharmacy, passed the California Assembly this week and now awaits action in the state senate. The legislation is supported by the California Pharmacists Association.
Thomas Siepka was named vice president for hospital and health systems by APC Corporate Patron Gates Healthcare Associates, a pharmaceutical and healthcare consulting firm in Middleton, Mass. He “will lead a team of experts providing clients clinical, programmatic, and regulatory counsel and support.”
…for being named one of the Top 5 Small Businesses of 2021 by the Cobb Chamber Of Commerce in Marietta, Ga.
Its president and CEO, Shawn Hodges, happens to be APC’s board chair.
The good folks at FDA Law Blog have the second in their series “I Hear You Knockin’… Preparing for and Managing DEA Inspections.” This one focuses on the inspectors and what they’re looking for.